Bank of America’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
RCM
TCM
VVM
DTC
CC
RI
VA
VCM
Bank of America's IPSC Position: Q1 2026 in Review
Bank of America increased its Century Therapeutics (IPSC) stake by 27,538% in Q1 2026, buying an estimated $304K and bringing the position to 145,099 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #5113.
Bank of America first reported a position in IPSC in Q2 2021 and has held it in 20 quarters since. The position peaked at $699K in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.
- Bank of America held 145,099 shares of Century Therapeutics worth $328K as of Q1 2026.
- Bank of America bought 144,574 Century Therapeutics shares in Q1 2026, an estimated $304K.
- Century Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5113 holding.
- Bank of America first reported a position in Century Therapeutics in Q2 2021 and has held it in 20 quarters since.
- Bank of America's Century Therapeutics position peaked at $699K in Q3 2021.
- 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.